These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 3699914)

  • 1. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
    Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 11. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis leukopenia and complement function with different dialyzers.
    Amadori A; Candi P; Sasdelli M; Massai G; Favilla S; Passaleva A; Ricci M
    Kidney Int; 1983 Dec; 24(6):775-81. PubMed ID: 6562280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE; Cheung AK; Ward DM; Henderson LW
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodialysis-induced activation of complement. Effects of different membranes.
    Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
    Blood Purif; 1986; 4(4):185-93. PubMed ID: 3790264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and activation of granulocytes and complement with two dialysis membranes.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 8 and biocompatibility of dialysis membranes.
    Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
    Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in haemodialysis: a comparison of new and re-used dialysers.
    Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
    Int J Artif Organs; 1986 Mar; 9(2):97-104. PubMed ID: 3699916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.